Letrozole Fempro 2.5 mg Anticancer Tablets – Global Export by Medswala Pharmacy

Medswala Pharmacy is a reliable exporter of Letrozole formulations, including Fempro 2.5 mg tablets, delivering high-quality oncology medicines worldwide with fast and secure logistics.

Product Overview

Letrozole Fempro 2.5 mg is an oral anticancer medication widely prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. It belongs to the class of aromatase inhibitors, which reduce estrogen production and help slow or stop the growth of certain breast cancers.

Key Features

• Active Ingredient: Letrozole 2.5 mg
• Dosage Form: Oral tablets
• Therapeutic Use: Breast cancer treatment
• Mechanism: Reduces estrogen levels by inhibiting aromatase enzyme
• High efficacy in long-term hormone therapy
• Manufactured under strict pharmaceutical quality standards

🌍 Fast & Secure Global Delivery

Medswala Pharmacy ensures timely and compliant international shipping of Letrozole Fempro 2.5 mg to major global destinations:

• United States
• Australia
• Japan
• Chile
• France
• United Kingdom
• Thailand
• Singapore
• Jamaica

All shipments are handled with proper documentation, secure packaging, and adherence to international pharmaceutical export regulations.

Why Choose Medswala Pharmacy?

• ✅ Trusted global pharmaceutical exporter
• ✅ Competitive pricing for bulk and wholesale orders
• ✅ Secure and discreet packaging
• ✅ Temperature-controlled logistics (if required)
• ✅ Regulatory compliance with international standards
• ✅ Dedicated support for export documentation

Packaging & Supply

• Standard blister packaging
• Bulk quantities available for distributors and pharmacies
• Custom export packaging and labeling support

Compliance & Quality Assurance

Medswala Pharmacy follows:

• WHO-GMP manufacturing standards
• International export compliance protocols
• Country-specific import regulations